Price of new hepatitis C drug questioned by U.S. medical experts

Health | 206754 hits | Mar 11 1:28 pm | Posted by: DrCaleb

An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc.

Comments

You need to be a member of CKA and be logged into the site, to comment on news.

Share

Who voted on this?

wildrosegirl Tue Mar 11, 2014 5:15 pm

All logos and trademarks in this site are property of their respective owner.
The comments are property of their posters, all the rest © 2025 by Canadaka.net